1
|
Su YH, Huang HC, Chen IL. An Association Between Pediatric Bronchiolitis and Atopic Dermatitis: A Multi-Institutional Electronic Medical Records Database Study From Taiwan. Clin Pediatr (Phila) 2024; 63:1208-1215. [PMID: 37997661 DOI: 10.1177/00099228231214087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2023]
Abstract
Atopic dermatitis (AD) is triggered by many environmental factors. We sought to determine the relationship between birth weight, infectious diseases, and AD. This retrospective cohort study analyzed data from the CGR Database for the period 2004 through 2015 in Taiwan. All diseases were classified using the International Classification of Disease codes. Logistic regression adjusted for birth weights and comorbidities were analyzed by SAS (version 9.4). P < .05 were considered statistically significant. In children with AD, bronchiolitis was significantly associated with the development of AD, whether the patients were aged < 2 years (odds ratio [OR] = 1.497; P = .014) or ≥ 2 years (OR = 1.882; P = .022). There was also no difference in the association between AD and different birth weights. We conclude that AD is associated with a previous history of bronchiolitis in children, regardless of age (less than or greater than 2 years).
Collapse
Affiliation(s)
- Yu-Han Su
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung City, Taiwan
| | - Hsin-Chun Huang
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung City, Taiwan
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - I-Lun Chen
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung City, Taiwan
- School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan
| |
Collapse
|
2
|
Arroyo AC, Robinson LB, James K, Li S, Faridi MK, Hsu S, Dumas O, Liu AY, Druzin M, Powe CE, Camargo CA. Maternal Hypertensive Disorders of Pregnancy and the Risk of Childhood Asthma. Ann Am Thorac Soc 2023; 20:1367-1370. [PMID: 37233740 PMCID: PMC10502887 DOI: 10.1513/annalsats.202212-994rl] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2022] [Accepted: 05/23/2023] [Indexed: 05/27/2023] Open
Affiliation(s)
| | | | - Kaitlyn James
- Harvard Medical SchoolBoston, Massachusetts and
- Massachusetts General HospitalBoston, Massachusetts and
| | - Sijia Li
- Massachusetts General HospitalBoston, Massachusetts and
| | | | - Sarah Hsu
- Massachusetts General HospitalBoston, Massachusetts and
- Broad InstituteCambridge, Massachusetts
| | | | - Anne Y. Liu
- Stanford University School of MedicineStanford, California
| | - Maurice Druzin
- Stanford University School of MedicineStanford, California
| | - Camille E. Powe
- Harvard Medical SchoolBoston, Massachusetts and
- Massachusetts General HospitalBoston, Massachusetts and
| | - Carlos A. Camargo
- Harvard Medical SchoolBoston, Massachusetts and
- Massachusetts General HospitalBoston, Massachusetts and
| |
Collapse
|
3
|
Zheng DX, Geller RJ, Robinson LB, Boos MD, Camargo CA. A comparison of case definitions for infant atopic dermatitis in a multicenter prospective cohort study. Health Sci Rep 2021; 4:e324. [PMID: 34268451 PMCID: PMC8273877 DOI: 10.1002/hsr2.324] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Revised: 06/18/2021] [Accepted: 06/22/2021] [Indexed: 11/12/2022] Open
Abstract
This study identified two infant AD case definitions that were strongly associated with known AD risk factors. These case definitions can be used to study novel AD risk factors in large cohort studies, potentially providing new insights into the epidemiology of infant AD.
Collapse
Affiliation(s)
- David X. Zheng
- Department of DermatologyCase Western Reserve University School of MedicineClevelandOhioUSA
- Department of Emergency MedicineMassachusetts General Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Ruth J. Geller
- Department of Emergency MedicineMassachusetts General Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Lacey B. Robinson
- Division of RheumatologyAllergy and Immunology, Massachusetts General Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| | - Markus D. Boos
- Division of DermatologySeattle Children's HospitalSeattleWashingtonUSA
| | - Carlos A. Camargo
- Department of Emergency MedicineMassachusetts General Hospital, Harvard Medical SchoolBostonMassachusettsUSA
| |
Collapse
|
4
|
Bermúdez Barrezueta L, Miñambres Rodríguez M, Palomares Cardador M, Torres Ballester I, López Casillas P, Moreno Carrasco J, Pino Vázquez A. Effect of prenatal and postnatal exposure to tobacco in the development of acute bronchiolitis in the first two years of life. An Pediatr (Barc) 2021; 94:385-395. [PMID: 34090635 DOI: 10.1016/j.anpede.2020.05.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Accepted: 05/06/2020] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION Environmental exposure to tobacco increases the risk of respiratory disease in infants. However, the impact of maternal smoking on the development of acute bronchiolitis has hardly been assessed. The aim of this study was to determine the incidence of acute bronchiolitis and to analyse the effect of prenatal and postnatal maternal smoking on the development of this disease. PATIENTS AND METHODS A prospective, observational study was performed on healthy newborns from a third level hospital born between October 2015 and February 2016. Questionnaires were completed by the mothers at discharge from maternity and followed-up for two years. These collected information about prenatal and postnatal smoking, lifestyle, family and personal history, and the development of bronchiolitis. A bivariate and multivariate logistic regression analysis was performed. RESULTS A total of 223 newborns were included, of whom 13.9% were exposed to tobacco smoking during gestation, 21.4% in the postnatal period, and 12.4% in both times. The incidence of bronchiolitis was 28.7% at one year of life, and 34.5% at two years. The multivariate analysis demonstrated that the prenatal and postnatal exposure to tobacco is an independent risk factor for the development of bronchiolitis (OR 4.38; 95% CI; 1.63-11.76), while prolonged breastfeeding is a protective factor (OR 0.13; 95% CI; 0.04-0.48). Other factors that were statistically significant were: atopic dermatitis (OR 2.91; 95% CI; 1.26-6.73), and gestational age (OR 1.42; 95% CI; 1.08-1.88). CONCLUSIONS Children exposed to prenatal and postnatal maternal smoking have a higher risk of suffering bronchiolitis. Reducing the smoking habit in women that intend to become pregnant must be a priority in preventive medicine.
Collapse
Affiliation(s)
- Lorena Bermúdez Barrezueta
- Unidad de Cuidados Intensivos Pediátricos y Neonatales, Hospital Clínico Universitario, Valladolid, Spain.
| | - María Miñambres Rodríguez
- Unidad de Cuidados Intensivos Pediátricos y Neonatales, Hospital Clínico Universitario, Valladolid, Spain
| | | | | | | | | | - Asunción Pino Vázquez
- Unidad de Cuidados Intensivos Pediátricos y Neonatales, Hospital Clínico Universitario, Valladolid, Spain
| |
Collapse
|
5
|
Efecto de la exposición prenatal y posnatal al tabaco en el desarrollo de bronquiolitis aguda durante los dos primeros años de vida. An Pediatr (Barc) 2021. [DOI: 10.1016/j.anpedi.2020.05.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
6
|
Seroogy CM, VanWormer JJ, Olson BF, Evans MD, Johnson T, Cole D, Barnes KL, Koepel TK, Dresen A, Meece J, Gangnon RE, Keifer MC, Bendixsen CG, Gern JE. Respiratory health, allergies, and the farm environment: design, methods and enrollment in the observational Wisconsin Infant Study Cohort (WISC): a research proposal. BMC Res Notes 2019; 12:423. [PMID: 31311588 PMCID: PMC6636141 DOI: 10.1186/s13104-019-4448-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2019] [Accepted: 07/05/2019] [Indexed: 01/29/2023] Open
Abstract
Epidemiologic and cross-sectional studies suggest that early life farming and animal exposures are associated with major health benefits, influencing immune development and modifying the subsequent risk of allergic diseases, including asthma. The Wisconsin Infant Study Cohort (WISC) study was established in central Wisconsin to test the hypothesis that early life animal farm exposures are associated with distinct innate immune cell maturation trajectories, decreased allergen sensitization and reduced respiratory viral illness burden during the first 2 years of life. Beginning in 2013, a total of 240 families have been enrolled, 16,522 biospecimens have been collected, and 4098 questionnaires have been administered and entered into a secure database. Study endpoints include nasal respiratory virus identification and respiratory illness burden score, allergic sensitization, expression of allergic disease, and anti-viral immune response maturation and profiles. The WISC study prospective design, broad biospecimen collections, and unique US rural community will provide insights into the role of environmental exposures on early life immune maturation profiles associated with protection from allergic sensitization and significant respiratory viral disease burden. The WISC study findings will ultimately inform development of new strategies to promote resistance to severe respiratory viral illnesses and design primary prevention approaches for allergic diseases for all infants.
Collapse
Affiliation(s)
- Christine M. Seroogy
- University of Wisconsin School of Medicine and Public Health, Madison, WI USA
- Division of Allergy, Immunology & Rheumatology, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, 1111 Highland Avenue, 4139 WIMR, Madison, WI 53705-2275 USA
| | - Jeffrey J. VanWormer
- Marshfield Clinic Research Institute, National Farm Medicine Center, Marshfield, WI USA
| | - Brent F. Olson
- Marshfield Clinic Research Institute, National Farm Medicine Center, Marshfield, WI USA
| | - Michael D. Evans
- University of Wisconsin School of Medicine and Public Health, Madison, WI USA
| | - Tara Johnson
- Marshfield Clinic Research Institute, National Farm Medicine Center, Marshfield, WI USA
| | - Deanna Cole
- Marshfield Clinic Research Institute, National Farm Medicine Center, Marshfield, WI USA
| | - Kathrine L. Barnes
- Marshfield Clinic Research Institute, National Farm Medicine Center, Marshfield, WI USA
| | | | - Amy Dresen
- University of Wisconsin School of Medicine and Public Health, Madison, WI USA
| | - Jennifer Meece
- Marshfield Clinic Research Institute, National Farm Medicine Center, Marshfield, WI USA
| | - Ronald E. Gangnon
- University of Wisconsin School of Medicine and Public Health, Madison, WI USA
| | - Matthew C. Keifer
- Department of Occupational Medicine, Marshfield Clinic, Marshfield, WI USA
- Present Address: Veterans Administration Puget Sound Healthcare System, Seattle, WA USA
| | - Casper G. Bendixsen
- Marshfield Clinic Research Institute, National Farm Medicine Center, Marshfield, WI USA
| | - James E. Gern
- University of Wisconsin School of Medicine and Public Health, Madison, WI USA
| |
Collapse
|
7
|
Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, Fu T, Worringer K, Brown HE, Wang J, Kaykas A, Karmacharya R, Goold CP, Sheridan SD, Perlis RH. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci 2019; 22:374-385. [PMID: 30718903 DOI: 10.1038/s41593-018-0334-7] [Citation(s) in RCA: 451] [Impact Index Per Article: 90.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Accepted: 12/19/2018] [Indexed: 12/11/2022]
Abstract
Synapse density is reduced in postmortem cortical tissue from schizophrenia patients, which is suggestive of increased synapse elimination. Using a reprogrammed in vitro model of microglia-mediated synapse engulfment, we demonstrate increased synapse elimination in patient-derived neural cultures and isolated synaptosomes. This excessive synaptic pruning reflects abnormalities in both microglia-like cells and synaptic structures. Further, we find that schizophrenia risk-associated variants within the human complement component 4 locus are associated with increased neuronal complement deposition and synapse uptake; however, they do not fully explain the observed increase in synapse uptake. Finally, we demonstrate that the antibiotic minocycline reduces microglia-mediated synapse uptake in vitro and its use is associated with a modest decrease in incident schizophrenia risk compared to other antibiotics in a cohort of young adults drawn from electronic health records. These findings point to excessive pruning as a potential target for delaying or preventing the onset of schizophrenia in high-risk individuals.
Collapse
Affiliation(s)
- Carl M Sellgren
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. .,Department of Psychiatry, Harvard Medical School, Boston, MA, USA. .,Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
| | - Jessica Gracias
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA.,Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
| | - Bradley Watmuff
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | - Jonathan D Biag
- Novartis Institutes for BioMedical Research, Cambridge, MA, USA
| | - Jessica M Thanos
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | | | - Ting Fu
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | | | - Hannah E Brown
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | - Jennifer Wang
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | - Ajamete Kaykas
- Novartis Institutes for BioMedical Research, Cambridge, MA, USA
| | - Rakesh Karmacharya
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA.,Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA, USA
| | | | - Steven D Sheridan
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.,Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | - Roy H Perlis
- Center for Quantitative Health, Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. .,Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
| |
Collapse
|
8
|
Dharma C, Lefebvre DL, Tran MM, Lu Z, Lou WYW, Subbarao P, Becker AB, Mandhane PJ, Turvey SE, Moraes TJ, Azad MB, Sears MR. Diagnosing atopic dermatitis in infancy: Questionnaire reports vs criteria-based assessment. Paediatr Perinat Epidemiol 2018; 32:556-567. [PMID: 30461044 DOI: 10.1111/ppe.12525] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2018] [Revised: 09/27/2018] [Accepted: 10/11/2018] [Indexed: 12/16/2022]
Abstract
BACKGROUND Persisting atopic dermatitis (AD) is known to be associated with more serious allergic diseases at later ages; however, making an accurate diagnosis during infancy is challenging. We assessed the diagnostic performance of questionnaire-based AD measures with criteria-based in-person clinical assessments at age 1 year and evaluated the ability of these diagnostic methods to predict asthma, allergic rhinitis and food allergies at age 5 years. METHODS Data relate to 3014 children participating in the Canadian Healthy Infant Longitudinal Development (CHILD) Study who were directly observed in a clinical assessment by an experienced healthcare professional using the UK Working Party criteria. The majority (2221; 73.7%) of these children also provided multiple other methods of AD ascertainment: a parent reporting a characteristic rash on a questionnaire, a parent reporting the diagnosis provided by an external physician and a combination of these two reports. RESULTS Relative to the direct clinical assessment, the area under the Receiver Operating Characteristic curve for a parental report of a characteristic rash, reported physician diagnosis and a combination of both were, respectively, 0.60, 0.69 and 0.70. The strongest predictor of asthma at 5 years was AD determined by criteria-based in-person clinical assessment followed by the combination of parental and physician report. CONCLUSIONS These findings suggest that questionnaire data cannot accurately substitute for assessment by experienced healthcare professionals using validated criteria for diagnosis of atopic dermatitis. Combining the parental report with diagnosis by a family physician might sometimes be appropriate (eg to avoid costs of a clinical assessment).
Collapse
Affiliation(s)
| | | | - Maxwell M Tran
- Department of Medicine, McMaster University, Hamilton, Canada
| | - Zihang Lu
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.,Department of Pediatrics, University of Toronto & Hospital for Sick Children, Toronto, Canada
| | - Wendy Y W Lou
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Padmaja Subbarao
- Department of Pediatrics, University of Toronto & Hospital for Sick Children, Toronto, Canada
| | - Allan B Becker
- Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Canada
| | - Piush J Mandhane
- Department of Pediatrics, University of Alberta, Edmonton, Canada
| | - Stuart E Turvey
- Department of Pediatrics, University of British Columbia, Vancouver, Canada
| | - Theo J Moraes
- Department of Pediatrics, University of Toronto & Hospital for Sick Children, Toronto, Canada
| | - Meghan B Azad
- Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Canada
| | - Malcolm R Sears
- Department of Medicine, McMaster University, Hamilton, Canada
| | | |
Collapse
|
9
|
Amat F, Plantard C, Mulliez A, Petit I, Rochette E, Verdan M, Henquell C, Labbé G, Heraud MC, Evrard B, Labbé A. RSV-hRV co-infection is a risk factor for recurrent bronchial obstruction and early sensitization 3 years after bronchiolitis. J Med Virol 2018; 90:867-872. [PMID: 29380391 PMCID: PMC7167020 DOI: 10.1002/jmv.25037] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2017] [Accepted: 01/05/2018] [Indexed: 02/02/2023]
Abstract
To assess risk factors of recurrent bronchial obstruction and allergic sensitization 3 years after an episode of acute bronchiolitis, whether after ambulatory care treatment or hospitalization. A monocentric prospective longitudinal study including infants aged under 1 year with acute bronchiolitis was performed, with clinical (severity score), biological (serum Krebs von den Lungen 6 antigen), and viral (14 virus by naso-pharyngeal suction detection) assessments. Follow-up included a quaterly telephone interview, and a final clinical examination at 3 years. Biological markers of atopy were also measured in peripheral blood, including specific IgEs towards aero- and food allergens. Complete data were available for 154 children. 46.8% of them had recurrent wheezing (RW). No difference was found according to initial severity, care at home or in the hospital, respiratory virus involved, or existence of co-infection. A familial history of atopy was identified as a risk factor for recurrent bronchial obstruction (60% for RW infants versus 39%, P = 0.02), as living in an apartment (35% versus 15%, P = 0.002). 18.6% of the infants were sensitized, with 48.1% of them sensitized to aeroallergens and 81.5% to food allergens. Multivariate analysis confirmed that a familial history of atopy (P = 0.02) and initial co-infection RSV-hRV (P = 0.02) were correlated with the risk of sensitization to aeroallergens at 3 years. Familial history of atopy and RSV-hRV co-infection are risk factors for recurrent bronchial obstruction and sensitization.
Collapse
Affiliation(s)
- Flore Amat
- Department of AllergologyCentre de l'Asthme et des AllergiesHôpital d'Enfants Armand TrousseauAssistance Publique‐Hôpitaux de ParisUPMC Univ Paris 06Sorbonne Universités; Equipe EPARInstitut Pierre Louis d'Epidémiologie et de Santé PubliqueINSERMFaculté de Médecine Saint‐Antoine ParisParisFrance
- Pediatric Emergency DepartmentCHU‐ Clermont‐FerrandClermont FerrandFrance
| | - Chloé Plantard
- Department of ImmunologyCHU‐Clermont‐FerrandClermont FerrandFrance
| | - Aurélien Mulliez
- Department of BiostatisticsCHU‐Clermont‐FerrandClermont FerrandFrance
| | - Isabelle Petit
- Investigation Clinical CenterCHU‐Clermont‐FerrandClermont FerrandFrance
| | | | - Matthieu Verdan
- Pediatric Emergency DepartmentCHU‐ Clermont‐FerrandClermont FerrandFrance
| | - Cécile Henquell
- Laboratory of VirologyCHU‐Clermont‐FerrandClermont FerrandFrance
| | - Guillaume Labbé
- Pediatric Emergency DepartmentCHU‐ Clermont‐FerrandClermont FerrandFrance
| | | | - Bertrand Evrard
- Department of BiostatisticsCHU‐Clermont‐FerrandClermont FerrandFrance
| | - André Labbé
- Pediatric Emergency DepartmentCHU‐ Clermont‐FerrandClermont FerrandFrance
- Laboratory of VirologyCHU‐Clermont‐FerrandClermont FerrandFrance
| |
Collapse
|
10
|
Bousquet J, Grattan C, Bieber T, Matricardi P, Simon HU, Wahn U, Muraro A, Hellings PW, Agache I. Prediction and prevention of allergy and asthma in EAACI journals (2016). Clin Transl Allergy 2017; 7:46. [PMID: 29214013 PMCID: PMC5712184 DOI: 10.1186/s13601-017-0185-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2017] [Accepted: 11/23/2017] [Indexed: 12/21/2022] Open
Abstract
The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members.
Collapse
Affiliation(s)
- Jean Bousquet
- MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.,INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France.,UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.,Euforea, Brussels, Belgium.,CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
| | - Clive Grattan
- Dermatology Centre, Norfolk and Norwich University Hospital, Norwich, UK
| | - Thomas Bieber
- Department of Dermatology and Allergy, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany
| | - Paolo Matricardi
- AG Molecular Allergology and Immunomodulation, Department of Pediatric Pneumology and Immunology, Charité Medical University, Berlin, Germany
| | - Hans Uwe Simon
- Institute of Pharmacology, University of Bern, Bern, Switzerland
| | - Ulrich Wahn
- Pediatric Department, Charité, Berlin, Germany
| | - Antonella Muraro
- Food Allergy Referral Centre Veneto Region, Department of Women and Child Health, Padua General University Hospital, Padua, Italy
| | - Peter W Hellings
- Euforea, Brussels, Belgium.,Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium
| | - Ioana Agache
- Faculty of Medicine, Transylvania University, Brasov, Romania
| |
Collapse
|
11
|
Balekian DS, Linnemann RW, Hasegawa K, Thadhani R, Camargo CA. Cohort Study of Severe Bronchiolitis during Infancy and Risk of Asthma by Age 5 Years. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE 2016; 5:92-96. [PMID: 27523277 DOI: 10.1016/j.jaip.2016.07.004] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/21/2016] [Revised: 06/30/2016] [Accepted: 07/01/2016] [Indexed: 11/26/2022]
Abstract
BACKGROUND Severe bronchiolitis (ie, bronchiolitis requiring hospital admission) is thought to markedly increase asthma risk, with 30%-50% developing asthma by age 5 years. To date, studies of this association are small, and most are from outside the United States. OBJECTIVE The objective of this study was to investigate the association between severe bronchiolitis and risk of asthma in a US birth cohort. METHODS We studied a cohort nested within the Massachusetts General Hospital Obstetric Maternal Study (MOMS), a prospective cohort of pregnant women enrolled during 1998-2006. Children of mothers enrolled in MOMS were included in the analysis if they received care within our health system (n = 3653). Diagnoses and medications were extracted from the children's electronic health records; we also examined pregnancy and perinatal risk factors collected for the underlying pregnancy study. RESULTS The birth cohort was 52% male, 49% white, and 105 infants (2.9%) had severe bronchiolitis. Overall, 421 children (11.5%) developed asthma by age 5 years. Among the children with severe bronchiolitis, 27.6% developed asthma by age 5 years. In multivariable logistic regression adjusting for 12 risk factors, severe bronchiolitis remained a strong risk factor for developing asthma by age 5 years (odds ratio 2.57; 95% confidence interval 1.61-4.09). CONCLUSIONS In a large Boston birth cohort, the frequency of severe bronchiolitis and childhood asthma was similar to published data. Among children with severe bronchiolitis, the risk of developing asthma was lower than prior studies but still high (27.6%). This difference may be due to different study designs, populations, and outcome definitions studied.
Collapse
Affiliation(s)
- Diana S Balekian
- Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass
| | - Rachel W Linnemann
- Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga
| | - Kohei Hasegawa
- Harvard Medical School, Boston, Mass; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass
| | - Ravi Thadhani
- Harvard Medical School, Boston, Mass; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Mass
| | - Carlos A Camargo
- Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass.
| |
Collapse
|